» Articles » PMID: 11119181

Taking Antiretroviral Therapy for HIV Infection: Learning from Patients' Stories

Overview
Publisher Springer
Specialty General Medicine
Date 2000 Dec 19
PMID 11119181
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe how people with HIV understand and experience the problem of adhering to antiretroviral medication regimens.

Design: We performed a qualitative study based on interviews with HIV-infected patients, including 46 clients of AIDS service organizations, who were sampled according to age, ethnicity, and injection drug use history, and a convenience sample of 15 patients. Interviews were conducted in English or Spanish and were audiotaped and transcribed.

Participants: Of 52 respondents who had prescriptions for antiretroviral therapy, 25 were randomly selected for in-depth analysis. Of these, 5 reported having an AIDS diagnosis, 15 reported symptoms they attributed to HIV, and 5 reported having no symptoms of HIV disease.

Measurements And Main Results: Investigators prepared structured abstracts of interviews to extract adherence-related data. One investigator compared the abstracts with the original transcripts to confirm the interpretations, and used the abstracts to organize and classify the findings. Most subjects (84%) reported recent nonadherent behavior, including ceasing treatment, medication "holidays," sleeping through doses, forgetting doses, skipping doses due to side effects, and following highly asymmetric schedules. Initially, most reported that they were not significantly nonadherent, and many did not consider their behavior nonadherent. Only a minority clearly understood the possible consequences of missing doses. Most said they had not discussed their nonadherence with their physicians.

Conclusions: Many people rationalize their difficulty in adhering to HIV treatment by deciding that the standard of adherence they can readily achieve is appropriate. Physicians should inquire about adherence-related behavior in specific detail, and ensure that patients understand the consequences of not meeting an appropriate standard.

Citing Articles

People Living with HIV and AIDS: Experiences towards Antiretroviral Therapy, Paradigm Changes, Coping, Stigma, and Discrimination-A Grounded Theory Study.

Beichler H, Kutalek R, Dorner T Int J Environ Res Public Health. 2023; 20(4).

PMID: 36833695 PMC: 9962544. DOI: 10.3390/ijerph20043000.


The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis.

Li H, Marley G, Ma W, Wei C, Lackey M, Ma Q AIDS Behav. 2016; 21(2):341-351.

PMID: 27613645 PMC: 5290204. DOI: 10.1007/s10461-016-1545-0.


Explanatory Models and Illness Experience of People Living with HIV.

Laws M AIDS Behav. 2016; 20(9):2119-29.

PMID: 26971285 PMC: 5064442. DOI: 10.1007/s10461-016-1358-1.


Evaluation of adherence to therapy in patients of chronic kidney disease.

Sontakke S, Budania R, Bajait C, Jaiswal K, Pimpalkhute S Indian J Pharmacol. 2016; 47(6):668-71.

PMID: 26729961 PMC: 4689023. DOI: 10.4103/0253-7613.169597.


Health literacy in HIV treatment: accurate understanding of key biological treatment principles is not required for good ART adherence.

Laws M, Danielewicz M, Rana A, Kogelman L, Wilson I AIDS Behav. 2014; 19(4):635-44.

PMID: 25354736 PMC: 4765166. DOI: 10.1007/s10461-014-0931-8.


References
1.
CARPENTER C, Fischl M, Hammer S, Hirsch M, Jacobsen D, Katzenstein D . Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA. 1998; 280(1):78-86. DOI: 10.1001/jama.280.1.78. View

2.
Altice F, Friedland G . The era of adherence to HIV therapy. Ann Intern Med. 1998; 129(6):503-5. DOI: 10.7326/0003-4819-129-6-199809150-00015. View

3.
Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

4.
Caron H . Compliance: the case for objective measurement. J Hypertens Suppl. 1985; 3(1):S11-7. View

5.
MORSE E, Simon P, Coburn M, Hyslop N, Greenspan D, Balson P . Determinants of subject compliance within an experimental anti-HIV drug protocol. Soc Sci Med. 1991; 32(10):1161-7. DOI: 10.1016/0277-9536(91)90093-r. View